We are live on
!
Find out more
OAG
Oakmont Advisory Group Portfolio holdings
AUM
$119M
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.7M
AUM Growth
–
Cap. Flow
+$93.4M
Cap. Flow
% of AUM
99.73%
Top 10 Holdings %
Top 10 Hldgs %
39.78%
Holding
116
New
116
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
quarters
Top 10 Avg Time Held
0
quarters
Top 20 Avg Time Held
0
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$11.8M |
| 2 |
DFUS
Dimensional US Equity ETF
DFUS
|
+$3.61M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$3.57M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$3.25M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$3.24M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.88% |
| 2 | Technology | 4.36% |
| 3 | Healthcare | 4.12% |
| 4 | Consumer Staples | 3.35% |
| 5 | Communication Services | 2.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Verizon
VZ
$191B
| $339K | 0.36% |
+8,312
| New | +$337K |
2025 Q4
0 quarters
|
|
77
Snap-on
SNA
$19.1B
| $338K | 0.36% |
+980
| New | +$335K |
2025 Q4
0 quarters
|
|
78
Gilead Sciences
GILD
$179B
| $335K | 0.36% |
+2,731
| New | +$332K |
2025 Q4
0 quarters
|
|
79
CME Group
CME
$94.6B
| $334K | 0.36% |
+1,225
| New | +$333K |
2025 Q4
0 quarters
|
|
80
Palo Alto Networks
PANW
$330B
| $334K | 0.36% |
+1,814
| New | +$366K |
2025 Q4
0 quarters
|
|
81
Illinois Tool Works
ITW
$74.9B
| $333K | 0.36% |
+1,354
| New | +$337K |
2025 Q4
0 quarters
|
|
82
Neurocrine Biosciences
NBIX
$14.6B
| $333K | 0.36% |
+2,350
| New | +$340K |
2025 Q4
0 quarters
|
|
83
Avery Dennison
AVY
$12.9B
| $333K | 0.35% |
+1,829
| New | +$316K |
2025 Q4
0 quarters
|
|
84
Accenture
ACN
$122B
| $332K | 0.35% |
+1,239
| New | +$315K |
2025 Q4
0 quarters
|
|
85
Cboe Global Markets
CBOE
$28.3B
| $331K | 0.35% |
+1,320
| New | +$328K |
2025 Q4
0 quarters
|
|
86
Procter & Gamble
PG
$337B
| $330K | 0.35% |
+2,301
| New | +$339K |
2025 Q4
0 quarters
|
|
87
Altria Group
MO
$112B
| $329K | 0.35% |
+5,707
| New | +$345K |
2025 Q4
0 quarters
|
|
88
Colgate-Palmolive
CL
$67.2B
| $327K | 0.35% |
+4,144
| New | +$325K |
2025 Q4
0 quarters
|
|
89
United Therapeutics
UTHR
$23.2B
| $324K | 0.35% |
+664
| New | +$309K |
2025 Q4
0 quarters
|
|
90
Palantir
PLTR
$454B
| $321K | 0.34% |
+1,808
| New | +$327K |
2025 Q4
0 quarters
|
|
91
CF Industries
CF
$17.4B
| $321K | 0.34% |
+4,156
| New | +$342K |
2025 Q4
0 quarters
|
|
92
Insulet
PODD
$9.13B
| $321K | 0.34% |
+1,130
| New | +$353K |
2025 Q4
0 quarters
|
|
93
Exelixis
EXEL
$14.5B
| $321K | 0.34% |
+7,325
| New | +$303K |
2025 Q4
0 quarters
|
|
94
VICI Properties
VICI
$24.9B
| $321K | 0.34% |
+11,412
| New | +$339K |
2025 Q4
0 quarters
|
|
95
T. Rowe Price
TROW
$22.3B
| $319K | 0.34% |
+3,115
| New | +$321K |
2025 Q4
0 quarters
|
|
96
Elanco Animal Health
ELAN
$11.1B
| $316K | 0.34% |
+13,974
| New | +$304K |
2025 Q4
0 quarters
|
|
97
Abbott
ABT
$169B
| $313K | 0.33% |
+2,501
| New | +$319K |
2025 Q4
0 quarters
|
|
98
Ralph Lauren
RL
$21.7B
| $312K | 0.33% |
+882
| New | +$301K |
2025 Q4
0 quarters
|
|
99
General Mills
GIS
$17.1B
| $312K | 0.33% |
+6,704
| New | +$319K |
2025 Q4
0 quarters
|
|
100
Vanguard International Dividend Appreciation ETF
VIGI
$8.84B
| $309K | 0.33% |
+3,382
| New | +$306K |
2025 Q4
0 quarters
|
|
Similar funds
BCM
FA
DFC
VIP
RMF
AA
AW
BAM
Oakmont Advisory Group's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Oakmont Advisory Group, which disclosed 116 positions worth $93.7M. Its ten largest holdings account for 40% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 18,961 shares worth $11.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, followed by Technology and Healthcare.
- Oakmont Advisory Group's largest Q4 2025 buy was Vanguard S&P 500 ETF: 18,961 shares worth $11.9M.
- Oakmont Advisory Group's ten largest holdings make up 40% of its $93.7M portfolio in Q4 2025.
- Oakmont Advisory Group disclosed 116 positions in Q4 2025, its first 13F filing on record.
Based on Oakmont Advisory Group's 13F filing for Q4 2025, filed 11 May 2026.